Wed, Apr 26, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Despite negative inflows in December, hedge funds see 10.1% increase in assets for 2013

Monday, January 20, 2014

Bailey McCann, Opalesque New York:

Assets going into hedge funds over the month of December were in negative territory, following positive flows during November. Despite that, investors increased their allocations by 10.1% overall in 2013, according to new data from eVestment. Investors redeemed an estimated $4.4bn during the month of December. Total hedge fund industry assets increased 10.1% for 2013, or $262.0bn, pushing them to $2.86tn overall. This puts industry AUM just below its all-time peak of $2.94tn set in June 2008. Performance accounted for approximately $190.1bn.

In terms of strategies, Equity hedge fund flows surpassed credit in Q4 for the first time since Q3 2011 and for only the second time since Q1 2010. Virtually all of equity funds net flows for the year came in the second half when the universe took in $32.3bn beginning just two months after UST 10-year rates bottomed in May.

Credit continued its bull run story with inflows of an estimated $79.6bn, including $3.7bn in December. Macro and managed futures fund redemptions were the primary reason hedge fund flows were negative in December and suffered their largest monthly redemptions since December 2008. Despite this, report data shows that Macro strategies produced asset weighted returns of 3.7% in 2013, well above their equal weighted average of 3.0%, but returns still lagged the industry overall.

Activist strategies led event driven/distressed flows and performance in 2013. Event driven a......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Investing - How Chipotle's comeback attracted big data robots and value investors alike[more]

    From Forbes.com: When William Ackman's ailing hedge fund Pershing Square Capital Management bet $1 billion on shares in Chipotle Mexican Grill beginning in July 2016, the stakes couldn't have been higher. Pershing Square was reeling from what would eventually be a near $4 billion loss in drugmaker V